Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mobolaji Olurinde"'
Autor:
April W. Armstrong, Timothy Fitzgerald, Robert R. McLean, Amanda Teeple, Jonathan P. Uy, Mobolaji Olurinde, Katelyn Rowland, Lin Guo, Ying Shan, Kristina Callis Duffin
Publikováno v:
Advances in Therapy. 40:2493-2508
Autor:
April W. Armstrong, Timothy Fitzgerald, Robert R. McLean, Amanda Teeple, Jonathan P. Uy, Mobolaji Olurinde, Katelyn Rowland, Lin Guo, Ying Shan, Kristina Callis Duffin
Publikováno v:
Dermatology and Therapy. 13:487-504
In clinical trials, treatment with the interleukin-23 inhibitor guselkumab was associated with significantly improved disease severity and patient-reported outcome measures (PROMs) among patients with moderate-to-severe plaque psoriasis. However, lim
Autor:
Timothy, Fitzgerald, Aimee M, Near, Hyunchung, Kim, Amanda, Teeple, Mobolaji, Olurinde, Katelyn, Rowland
Publikováno v:
Dermatology and Therapy. 12:741-752
Biologics have expanded the treatment options in the management of patients with moderate-to-severe psoriasis. The objective of this study was to describe patient characteristics and previous treatments in psoriasis patients newly treated with guselk
Autor:
Katelyn Rowland, Jonathan Uy, Abby S. Van Voorhees, April W. Armstrong, Timothy Fitzgerald, Robert R. McLean, Kristina Callis-Duffin, Ying Shan, Lin Guo, Amanda Teeple, Mobolaji Olurinde
Publikováno v:
Journal of the American Academy of Dermatology. 85:AB66
Autor:
Mobolaji Olurinde, April W. Armstrong, Abby S. Van Voorhees, Kristina Callis-Duffin, Robert R. McLean, Ying Shan, Jonathan Uy, Katelyn Rowland, Timothy Fitzgerald, Lin Guo, Amanda Teeple
Publikováno v:
Journal of the American Academy of Dermatology. 85:AB122
Autor:
Jianhua Sui, Wenhui Li, Larry J. Anderson, Hyeryun Choe, Michael Farzan, Akikazu Murakami, William J. Bellini, Wayne A. Marasco, Mobolaji Olurinde, Azaibi Tamin, Leslie J. Matthews, Swee Kee Wong, Michael Moore, Aimee St. Clair Tallarico
Publikováno v:
Proceedings of the National Academy of Sciences
Effective prophylaxis and antiviral therapies are urgently needed in the event of reemergence of the highly contagious and often fatal severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) infection. We have identified eight recombinant hum